Cited by 1,018Atrial Fibrillation Management and OutcomesCardiovascular and Diving-Related ComplicationsAcute Ischemic Stroke Management

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation: A Randomized Clinical Trial

Reddy, Vivek Y., Sievert, Horst, Halperin, Jonathan, Doshi, Shephal K., Buchbinder, Maurice, Neuzil, Petr, Huber, Kenneth, Whisenant, Brian, Kar, Saibal, Swarup, Vijay, Gordon, Nicole, Holmes, David·2014·JAMA

DOI 10.1001/jama.2014.15192

Open this paper in CoChat — free account

Abstract

IMPORTANCE: While effective in preventing stroke in patients with atrial fibrillation (AF), warfarin is limited by a narrow therapeutic profile, a need for lifelong coagulation monitoring, and multiple drug and diet interactions. OBJECTIVE: To determine whether a local strategy of mechanical left atrial appendage (LAA) closure was noninferior to warfarin. DESIGN, SETTING, AND PARTICIPANTS: PROTECT AF was a multicenter, randomized (2:1), unblinded, Bayesian-designed study conducted at 59 hospitals of 707 patients with nonvalvular AF and at least 1 additional stroke risk factor (CHADS2 score ≥1). Enrollment occurred between February 2005 and June 2008 and included 4-year follow-up through October 2012. Noninferiority required a posterior probability greater than 97.5% and superiority a probability of 95% or greater; the noninferiority margin was a rate ratio of 2.0 comparing event rates between treatment groups. INTERVENTIONS: Left atrial appendage closure with the device (n = 463) or warfarin (n = 244; target international normalized ratio, 2-3). MAIN OUTCOMES AND MEASURES: A composite efficacy end point including stroke, systemic embolism, and cardiovascular/unexplained death, analyzed by intention-to-treat. RESULTS: At a mean (SD) follow-up of 3.8 (1.7) years (2621 patient-years), there were 39 events among 463 patients (8.4%) in the device group for a primary event rate of 2.3 events per 100 patient-years, compared with 34 events among 244 patients (13.9%) for a primary event rate of 3.8 events per 100 patient-years with warfarin (rate ratio, 0.60; 95% credible interval, 0.41-1.05), meeting prespecified criteria for both noninferiority (posterior probability, >99.9%) and superiority (posterior probability, 96.0%). Patients in the device group demonstrated lower rates of both cardiovascular mortality (1.0 events per 100 patient-years for the device group [17/463 patients, 3.7%] vs 2.4 events per 100 patient-years with warfarin [22/244 patients, 9.0%]; hazard ratio [HR], 0.40; 95% CI, 0.21-0.75; P = .005) and all-cause mortality (3.2 events per 100 patient-years for the device group [57/466 patients, 12.3%] vs 4.8 events per 100 patient-years with warfarin [44/244 patients, 18.0%]; HR, 0.66; 95% CI, 0.45-0.98; P = .04). CONCLUSIONS AND RELEVANCE: After 3.8 years of follow-up among patients with nonvalvular AF at elevated risk for stroke, percutaneous LAA closure met criteria for both noninferiority and superiority, compared with warfarin, for preventing the combined outcome of stroke, systemic embolism, and cardiovascular death, as well as superiority for cardiovascular and all-cause mortality. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00129545.

Integrity signals

Registry

Crossref · 10.1001/jama.2014.15192

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bayesian Data Analysis
Gelman, A., Carlin, J. B., Stern, H. S., & Rubin, D. B. (2003) · doi:10.1201/9780429258480 · Cited by 27,276
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Self-citation
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793 · cited 2×
“Carl Jacobs (Piedmont Hospital, Atlanta [2]); Rajesh Dave (Harrisburg Hospital, Harrisburg, Pennsylvania [1]); John Young (Lindner Clinical Trial Center, Cincinnati, Ohio [1]); David Lasorda (Allegheny General Hospital, Pittsburgh [1]).”
Background
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
Holmes, D. R., Reddy, V. Y., Turi, Z. G., Doshi, S. K., Sievert, H., Buchbinder, M., Mullin, C. M., & Sick, P. B. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61343-x · Cited by 2,242
Self-citation
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,070
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haı̈ssaguerre, M., et al. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.04.005 · Cited by 1,690
Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
Blackshear, J. L., & Odell, J. A. (1996) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00887-x · Cited by 1,686 · cited 3×
“Turi (Cooper Hospital, Camden, New Jersey [4]); Bryan Raybuck (INOVA Research Center, Falls Church, Virginia [3]); Ron Waksman, Horst Sievert (Washington Hospital Center, Washington, DC [4]); Steven Kalbfleisch (Ohio State University, Columbus [3]); Michael Mooney (Abbott Northwestern Hospital, Minneapolis [3]); Willi…”
Background

Show all 25 references

Sorted by citations

Items 801–900 of 1,000

WATCHMAN: Trials and Registries Results
Saw, J., Kar, S., & Price, M. J. (2015) · Contemporary cardiology · doi:10.1007/978-3-319-16280-5_11
Self-citation
Anatomische, physiologische und pathophysiologische Grundlagen
Winkhardt, M. (2017) · Springer eBooks · doi:10.1007/978-3-662-54585-0_2
Percutaneous left atrial appendage closure: here to stay
Eng, L., & Saw, J. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.08.99
Barriers for a Wider Use of Left Atrial Appendage Occlusion as an Alternative to Oral Anticoagulation
de Prado, A. P. (2016) · Journal of Cardiology & Current Research · doi:10.15406/jccr.2016.06.00217
Iatrogenic ischemic strokes: other causes
Tsiskaridze, A., Lindgren, A. G., & Qureshi, A. I. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781139775397.012
Stroke after discontinuation of preventive medications
Demeestere, J., & Thijs, V. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781139775397.015
Left Atrial Appendage Closure (LAAC)
Varghese, A., Calvert, P. A., & Ludman, P. (2017) · Springer eBooks · doi:10.1007/978-1-4471-4981-1_2
OBSOLETE: Clinical Trials for Atrial Fibrillation - What do we know?
Wilton, S. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99783-6
Intrazerebrale Blutungen unter oraler Antikoagulation
Beynon, C., & Unterberg, A. W. (2017) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-017-0293-x
Difficult Cases and Complications from the Catheterization Laboratory: Left Atrial Appendage Perforation During Percutaneous Closure
Saccà, S., & Umemoto, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-43757-6_18
Percutaneous Left Atrial Appendage Closure: Rational, Patient Selection, and Preoperative Evaluation
Mennuni, M. G., Penzo, C., Ferrante, G., Stefanini, G. G., & Reimers, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-43757-6_15
Perspectives on the modern management of non-valvular atrial fi brillation
Gopal, R., & Tayebjee, M. H. (2017) · SA Heart · doi:10.24170/12-2-1721
Interventional Left Atrial Appendage Closure: Focus on Practical Implications
Fastner, C., Behnes, M., Ansari, U., El‐Battrawy, I., & Borggrefe, M. M. (2017) · InTech eBooks · doi:10.5772/67773
Safety and Efficacy of LAA Closure
Bergmann, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-51431-4_2
Trombosis tardía asociada a dispositivo de cierre percutáneo de orejuela. ¿Es poco frecuente o está infradiagnosticada?
Bengla-Limpo, B., López-Mínguez, J. R., Millán-Núñez, M. V., Fuentes‐Cañamero, M. E., González-Fernández, R., & Nogales‐Asensio, J. M. (2017) · Revista Española de Cardiología · doi:10.1016/j.recesp.2017.06.002
Cierre percutáneo de la orejuela izquierda: revisión sistemática de los resultados de seguridad y eficacia
Hernández, J. M., Urso, S., Tena, M. Á., Sádaba, R., & Portela, F. (2017) · Cirugía Cardiovascular · doi:10.1016/j.circv.2017.06.002
CОВРЕМЕННЫЕ СТРАТЕГИИ ПРОФИЛАКТИКИ ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ
Kalemberg, A. A., Давтян, К. В., Simonyan, G. Y., & Shatakhtsyan, V. S. (2016) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2016-2-7-13
The Role of Multimodality Cardiac Imaging in the Management of Patients with Atrial Fibrillation
Jung, J. I. (2017) · Cardiovascular Imaging Asia · doi:10.22468/cvia.2017.00038
Highlights from Heart Rhythm Society 2017: Atrial Fibrillation
Doshi, R. N. (2017) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2017.080801
Left Atrial Appendage Closure: Is the Strategy Enough to Lower Long-Term Stroke Risk?
Vuddanda, V. L. K., Turagam, M. K., & Lakkireddy, D. (2017) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-017-0555-4
Late Thrombosis Associated With Left Atrial Appendage Closure Devices. Is It Rare or Is It Underdiagnosed?
Bengla-Limpo, B., López-Mínguez, J. R., Millán-Núñez, M. V., Fuentes‐Cañamero, M. E., González-Fernández, R., & Nogales‐Asensio, J. M. (2017) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.06.024
Exploring the dark side of left atrial appendage closure devices
Santangeli, P., & Epstein, A. E. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13358
Vorhofohrverschluss – reif für die Praxis?
Stöllberger, C., & Schneider, B. (2017) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-117486
Left atrial appendage occlusion is promising, not concerning
Korsholm, K., & Nielsen‐Kudsk, J. E. (2017) · EuroIntervention · doi:10.4244/eij-d-17-00457r
Fermeture d’auricule et pathologie embolique
Akodad, M., & Garot, P. (2017) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2017.10.003
Der Verschluss des linken Vorhofohrs bei nichtvalvulärem Vorhofflimmern zur Prophylaxe von Tod, Schlaganfall und Blutungen
Gloekler, S., Hajredini, B., Rycerz, S., Jäckle, S., & Jung, W. (2017) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-017-0536-9
Percutaneous left atrial appendage closure versus oral anticoagulant: A bird in the hand is worth two in the bush?
Bai, R. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.10.062
Fermeture percutanée de l’auricule gauche : supprimer le risque thromboembolique de la fibrillation auriculaire ?
Kamtchueng, P. (2017) · JMV-Journal de Médecine Vasculaire · doi:10.1016/j.jdmv.2017.12.001
L’occlusion de l’auricule gauche peut-elle remplacer les anticoagulants oraux dans la prévention des accidents vasculaires cérébraux au cours de la fibrillation auriculaire ?
Juliard, J., Brochet, É., Aubry, P., Tadros, V., Ducrocq, G., Ou, P., & Vahanian, A. S. (2018) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2017.11.003
The Role of the Left Atrial Appendage in Stroke and Arrhythmia Provocation
Rajabali, A., Badhwar, N., & Lee, R. J. (2018) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-018-0576-7
Left Atrial Appendage Occlusion, Shared Decision-Making, and Comprehensive Atrial Fibrillation Management
Hoskins, M. H., Patel, A. M., & DeLurgio, D. B. (2018) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2017.12.006
Schlaganfallprävention in der klinischen Praxis
Hartung, J. J., Skurk, C., Leistner, D. M., & Landmesser, U. (2018) · Der Klinikarzt · doi:10.1055/a-0605-7652
Anticoagulant Strategies for Electrophysiology Procedures
BELDNER, S. J., & Stern, D. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-73709-6_12
Percutaneous Occlusion of the Left Atrial Appendage with the Watchman Device in an Active Duty Sailor with Atrial Fibrillation and Recurrent Thromboembolism Despite Appropriate Use of Oral Anticoagulation
Cox, J. M., Choi, A. J., Oakley, L. S., Francisco, G. M., & Nayak, K. R. (2018) · Military Medicine · doi:10.1093/milmed/usy099
Thrombosis in Atrial Fibrillation
Jones, G. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812615-8.00023-5
Left-Atrial Appendage Occluders
Younis, A., Grupper, A., Beinart, R., & Glikson, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812615-8.00036-3
Vorhofohrverschluss für Patienten mit Vorhofflimmern
Sievert, H., Bertog, S. C., & Darius, H. (2018) · CardioVasc · doi:10.1007/s15027-018-1403-2
Self-citation
Surgical and Implanted Devices for the Left Atrial Appendage
Gautam, S., & Payne, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55429-9.00011-x
Anticoagulación tras una hemorragia cerebral
Masjuán, J., & Vera, R. (2018) · Medicina Clínica · doi:10.1016/s0025-7753(18)30667-5
Targeting Atrial Fibrillation Patients for Left Atrial Appendage Occlusion with Epicardial Closing Devices
Crijns, H. J. G. M., Spitzer, S. G., & Tondo, C. (2018) · European Journal of Arrhythmia & Electrophysiology · doi:10.17925/ejae.2018.4.2.53
Atrial Fibrillation
Kumar, S., & Michaud, G. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00076-6
Catheter Ablation
Biase, L. D., Aagaard, P., Santangeli, P., & Natale, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00124-3
Patient-Specific Quantification of the Relationship Between the Left Atrium Pressure and the Ostial Diameter of the Left Atrial Appendage
Gao, S. T. (2018) · Digital Commons - DU (University of Denver)
ELIMINATION OF THE LEFT ATRIAL APPENDAGE IN THE PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
Gancarczyk, U., Przewłocki, T., Podolec, P. S., & Komar, M. (2019) · Wiadomości Lekarskie · doi:10.36740/wlek201909222
Quantitation of the Left Atrial Appendage
Faddis, M. N. (2019) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.119.010109
非弁膜症性心房細動に対するMICS：ポート・アクセス完全内視鏡下手術（WOLF-OHTSUKA 法）
俊哉, 大. (2019) · 心臓 · doi:10.11281/shinzo.51.29
Was bringt der Verschluss des linken Vorhofohrs?
Vogel, U. &. (2015) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-015-1449-y
Intracardiac Echocardiogram for Watchman Implantation in Patients With Atrial Fibrillation
Biase, L. D., & Romero, J. E. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.01.009
LAA-Okkluder versus orale Antikoagulation bei nonvalvulärem Vorhofflimmern in klinischen Studien: Wie ist die Evidenz?
Barth, U. (2020) · Der Kardiologe · doi:10.1007/s12181-020-00397-x
Making Left Atrial Appendage Occlusion Even Safer
Kapadia, S. R., Wazni, O., & Krishnaswamy, A. (2020) · Structural Heart · doi:10.1080/24748706.2020.1766730
Practice makes Perfect: What have We Learned from Many Years of Experience with the WATCHMAN?
Shepard, R. K., & Ellenbogen, K. A. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.03.007
Percutaneous left Atrial Appendage Occlusion for Stroke Prevention in Patients with Atrial Fibrillation
Diener, H., & Landmesser, U. (2020) · Future Neurology · doi:10.2217/fnl-2020-0001
Discriminating factors excluding patients from a catheter-based left atrial appendage closure and an outcome analysis of non-intervened and intervened patients
Fastner, C., Jabbour, C., Behnes, M., Sartorius, B., Wenke, A., El‐Battrawy, I., Ansari, U., Borggrefe, M. M., & Akın, İ. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.98652
Drugs, Devices, and Procedural Therapies to Prevent Recurrent Cardiogenic Embolic Stroke
Hankey, G. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316286234.019
Prevention of Ischemic Stroke
Kam, W., & Husseini, N. E. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_24
Imaging for SHD interventions
Thaden, J. J., & Maalouf, J. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-67278-8.00012-0
Watchman™ Left Atrial Appendage Closure Device
Iyengar, S., Nguyen, J., Tay, E. L. W., & Hou, D. (2020) · doi:10.1002/9781119383031.ch29
Addressing Stroke Risk in a Patient with CREST Syndrome and Atrial Fibrillation with Left Atrial appendage Occluder Device (WATCHMAN)
Alkhayru, A. (2021) · Clinical Cardiology and Cardiovascular Interventions · doi:10.31579/2641-0419/123
Katetrizačný uzáver uška ľavej predsiene, včasné a neskoré komplikácie / Left atrial appendage occlusion, early and late complications
Mišíková, S., Juhás, S., Ondušová, D., & Šimurda, M. (2021) · Cardiology letters · doi:10.4149/cardiol_2020_5_6_6
Neurologic complications of implantable devices
Ortiz-Garcia, J., Nathan, S., & Brorson, J. R. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819814-8.00019-6
Left Atrial Appendage Closure
Hamm, W., & Bauer, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-39611-8_12
Left atrial appendage device closure in an adult patient with univentricular heart: First reported case
Kheiwa, A., Fearon, C., Mandapati, R., Doctorian, T., Contractor, T. A., & Bhardwaj, R. (2021) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2021.04.004
Verschluss des linken Vorhofohrs bei nichtvalvulärem Vorhofflimmern: Datenlage, aktuelle Studien, offene Fragen
Häusler, K. G., Endres, M., & Landmesser, U. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin
Initial Experience and Results of Combined Treatment for Atrial Fibrillation: Catheter Ablation with High-Power Short Duration Ablation and Left Atrial Appendage Closure
VASSALLO, F. S., Serpa, E. G., Walker, B. R., Meigre, L. L., Carloni, H., Simões, A., da Cunha, C. L., Pezzin, F., Loureiro, K., Amaral, D., et al. (2021) · Journal of Cardiac Arrhythmias · doi:10.24207/jca.v34i2.3440
Reply
Nazir, S., Ahuja, K. R., Kolte, D. S., & Kapadia, S. R. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.04.028
A Prospective, Multi-Center, Single-Arm Study of a Novel Double-Disc Left Atrial Appendage Closure System
Li, S., Chen, W., Zhu, M., Ge, J., Zhou, D., Zhang, X., Wang, J., Fan, Y., Wang, Y., Chang, D., et al. (2021) · International Journal of Heart Rhythm · doi:10.4103/ijhr.ijhr_5_21
Is Left Atrial Appendage Occlusion Always Better than Direct Oral Anticoagulants?
Kim, J. (2021) · Korean Circulation Journal · doi:10.4070/kcj.2021.0194
Strategies for Recovering an Embolized Percutaneous Device
Nestelberger, T., Alfadhel, M., McAlister, C., Samuel, R., & Saw, J. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01554-8
Left Atrial Appendage Closure in Atrial Fibrillation Patients
Benedetto, M., & Fazio, G. (2021) · SunText Review of Medical & Clinical Research · doi:10.51737/2766-4813.2021.035
Left Atrial Appendage Occlusion Device Placement and the Integration of Echocardiography–Fluoroscopy Fusion Imaging
Maresch, A. C., Chacon, M. M., & Markin, N. W. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.07.004
Association of Body Mass Index With Outcomes in Patients Undergoing Percutaneous Left Atrial Appendage Closure With the Watchman Device
Minhas, A. M. K., Gul, S., Sheikh, A. B., Nazir, S., Ahuja, K. R., Anwar, M. N., Dani, S. S., Goel, S. S., Virani, S. S., & Alam, M. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.101009
Medical and Device Therapy for Stroke Prevention in Patients With Atrial Fibrillation
Huang, S., Safavi‐Naeini, P., & Rasekh, A. (2021) · Texas Heart Institute Journal · doi:10.14503/thij-21-7549
Comparison of variants of anesthesia for left atrial appendage occlusion in patients with atrial fbrillation
Вольфович, П. Д., Merkulova, I. A., Alieva, A. K., Gadzhibekov, N. C., Avetisyan, É. A., Kochergin, N. А., & Ganyukov, V. I. (2021) · Messenger of Anesthesiology and Resuscitation · doi:10.21292/2078-5658-2021-18-5-30-39
Left Atrial Appendage Closure: Where Do We Stand Now?
Ellenbogen, K. A., & Ashley, P. (2021) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2021.11.033
[Cytogenic characteristics and virogenic status of lymphoid cells from malignant baboon lymphomas].
Агрба, В. З., Medvedeva, N. M., Яковлева, Л. А., Chikobava, M. G., Araviashvili, D. E., Vv, T., & Lapin, B. A. (1999) · PubMed
Elena Asins, Premio Nacional de Artes Plásticas 2011: Utilizo tres lenguajes, el musical, el verbal y el plástico
García, A. G. (2011) · Hispana
Secondary Prevention of Cardioembolic Stroke
Furie, K. L., Yaghi, S. R., & Khan, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00064-8
Atrial Fibrillation
Hanna, E. B. (2022) · Wiley eBooks · doi:10.1002/9781119832737.ch10
Cardiac Arrhythmias
Gutierrez, C., & Hatamy, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-54441-6_84
Appendix
de Luna, A. B., & FCCS, A. B. M. F. F. (2017) · doi:10.1002/9781119212782.app1
Stroke and/or transient ischemic attack prophylaxis from the perspective of an interventional cardiologist
Janek, B. (2022) · Intervenční a akutní kardiologie · doi:10.36290/kar.2022.007
Follow Up imaging After Left Atrial Appendage Occlusion–Something or Nothing and for How Long?
Nestelberger, T., Alfadhel, M., McAlister, C., & Saw, J. (2022) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2021.11.008
Left atrial appendage closure in patients with intracranial hemorrhage: the clock is ticking — to take the bull by the horn or wait for a randomized controlled trial
Alfie, A., & Müller, P. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01180-6
Pulmonary Embolic Disease and Cardiac Masses and Tumors
Gladish, G. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-69538-1.00042-2
Evaluation and Interventional Management of Cardiac Dysrhythmias
Hoff, S. J. (2022) · Surgical Clinics of North America · doi:10.1016/j.suc.2022.01.003 · Cited by 1
Interventioneller Vorhofohrverschluss
Fink, T., Metzner, A., Kück, K., & Tilz, R. R. (2015) · CardioVasc · doi:10.1007/s15027-015-0688-7
Sekundärprävention
Köhrmann, M., Kraft, P., Reiff, T., & Ringleb, P. A. (2020) · Elsevier eBooks · doi:10.1016/b978-3-437-23431-6.00012-6
Longitudinal Case-Based Presentations in HCM
Hafiz, A. M., Elias, J. A., Mody, K. P., Kahn, J. M., Khera, S., Kalra, A., & Naidu, S. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-92423-6_31
Cardiac Arrhythmias
Gutierrez, C., & Hatamy, E. (2020) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_84-2
Left atrial appendage occlusion in patients with blood cell dyscrasia
Kewcharoen, J., Shah, K. B., Bhardwaj, R., Contractor, T. A., Turagam, M. K., Mandapati, R., Lakkireddy, D., & Garg, J. (2022) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14550
Nothing is ever so good that it cannot stand a little revision: The advance of WATCHMAN iterations
Tarantini, G., & Cardaioli, F. (2022) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30309
Diagnosis and Management of Heart Disease
Stolker, J. M., & Rich, M. W. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108942751.013
Left Atrial Appendage Closure for Stroke Prevention
Asıl, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105140
Case report: Intrapericardial thrombus aspiration in early stage of pericardial thrombosis for cardiac tamponade complicating percutaneous left atrial appendage closure
Mo, B., Wu, C.-Q., Wang, Q., & Li, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.924570
Sustitución de válvula mitral en paciente con dispositivo previo de cierre de orejuela izquierda Amulet Amplatzer
Hernández‐Estefanía, R., Aceña, Á., Tomás, M., Ibañez, C., García-Vega, M. I., & Aldámiz‐Echevarría, G. (2022) · Cirugía Cardiovascular · doi:10.1016/j.circv.2022.07.004
Recent Advances in Catheter Ablation for Atrial Fibrillation and Non-pharmacological Stroke Prevention
Kaushik, N., Chapman, J. A., Gillaspie, A., Ackerman, S. J., Gallagher, P. L., Mallick, D. C., & Bailin, S. J. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106319
Transcatheter Left Atrial Appendage Occlusion: A Multi-Center Real Life Experience
Arow, Z., Hornik‐Lurie, T., Gabarin, M., Omelchenko, A., Barashi, R., Arnson, Y., Assali, A., & Pereg, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11236944
Der interventionelle Vorhofohrverschluss: eine Alternative zur oralen Antikoagulation
Omran, H., Büllesfeld, L., & Heinrich, J. (2022) · Aktuelle Kardiologie · doi:10.1055/a-1953-0255
Morbid obesity is associated with increased procedural complications and worse in-hospital outcomes after percutaneous left atrial appendage occlusion device implantation
Agarwal, S., Asad, Z. U. A., Khan, M. Z., Messele, L. F., Darden, D. J., Pasupula, D. K., Singh, G. D., Srivatsa, U. N., Zahid, S., Balla, S., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.12.030
Percutaneous Interventions for Structural Heart Disease in the Elderly
Rahman, F., Resar, J. R., & Czarny, M. J. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-16594-8_7

Authors: Reddy, V. Y., Sievert, H., Halperin, J., Doshi, S. K., Buchbinder, M., Neuzil, P., Huber, K., Whisenant, B., Kar, S., Swarup, V., Gordon, N., & Holmes, D.
Affiliations: Na Homolce Hospital (CZ)
Cardiovascular Center Frankfurt (DE)
Icahn School of Medicine at Mount Sinai (US)
Saint John's Health Center (US)
Foundation for Cardiovascular Medicine, La Jolla, California
Homolka Hospital, Prague, Czech Republic
Saint Luke's Hospital (US)
Intermountain Medical Center (US)
Cedars-Sinai Medical Center (US)
Arizona Heart Rhythm Center, Scottsdale
Boston Scientific (United States) (US)
Mayo Clinic (US)
Corresponding author: Reddy, Vivek Y.
ORCID: Reddy, Vivek Y.
Halperin, Jonathan
Doshi, Shephal K.
Buchbinder, Maurice
Whisenant, Brian
Kar, Saibal
Holmes, David
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2014-11-19
Volume: 312
Issue: 19
Pages: 1988
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2014.15192
OpenAlex: W2112970567
Cited by: 1,018
References: 25
Citations by year: 2026: 73 · 2025: 86 · 2024: 87 · 2023: 102 · 2022: 97 · 2021: 84 · 2020: 75 · 2019: 58 · 2018: 87 · 2017: 104 · 2016: 75 · 2015: 77 · 2014: 6
FWCI: 59.90
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords: left atrial appendage closure, warfarin, atrial fibrillation, stroke prevention, systemic embolism, cardiovascular mortality, non-inferiority, non-valvular atrial fibrillation, CHADS2 score, anticoagulation, international normalized ratio, bleeding complications, quality of life, patient satisfaction, patient-reported outcomes
MeSH terms: Aged, Aged, 80 and over, Anticoagulants, Atrial Fibrillation, Bayes Theorem, Cardiovascular Diseases, Embolism, Female, Cardiac Catheterization, Humans, Male, Middle Aged, Risk Factors, Warfarin, Survival Analysis, Treatment Outcome, Prosthesis Implantation, Atrial Appendage, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation: A Randomized Clinical Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks